Print

Reduction in Volume in Hippocampus Region of Brain Seen in Psychotic Disorders

EMBARGOED FOR RELEASE: 3 P.M. (CT), WEDNESDAY, MAY 14, 2014

Media Advisory: To contact author Matcheri S. Keshavan, M.D., call Kelly Lawman at 617-667-7305 or email klawman@bidmc.harvard.edu.

JAMA Psychiatry Study Highlights

Bottom Line:  Reduction in brain volume in the hippocampus (a region related to memory) was seen in patients with the psychotic disorders schizophrenia (SZ), schizoaffective disorder (SZA) and psychotic bipolar disorder (BPP).

Authors: Ian Mathew, B.A., of Harvard Medical School, Boston, and colleagues.

Background: The pathophysiology of psychotic disorders remains unclear, especially SZ. Changes in volume in the hippocampus are a hallmark of SZ. Advances in image processing allow for the precise parceling of specific hippocampal areas.

How the Study Was Conducted: The authors conducted a neuroimaging study in patients with psychotic disorders and healthy volunteers as part of the multisite Bipolar-Schizophrenia Network on Intermediate Phenotypes (Wayne State University, Harvard University, Maryland Psychiatric Research Center, University of Chicago/University of Illinois at Chicago, University of Texas Southwestern Medical Center at Dallas and the Institute of Living/Yale University). The study included patients with SZ (n=219), SZA (n=142) or BPP (n=188), along with 337 healthy volunteers.

Results: Volume reductions in the hippocampus were seen in all three groups of patients with psychotic disorders when compared with healthy volunteers. Smaller volumes also were seen across specific hippocampal areas in all three psychotic disorders groups. Hippocampal volumes were associated with the severity of psychosis, declarative memory and overall cognitive performance.

Discussion: “This study firmly establishes the hippocampus as one of the key nodes in the pathway to psychosis. Understanding the functional consequences and etiological underpinnings of these alterations will likely facilitate better prediction and targeted intervention in psychoses.”

(JAMA Psychiatry. Published online May 14, 2014. doi:10.1001/jamapsychiatry.2014.453. Available pre-embargo to the media at http://media.jamanetwork.com.)

Editor’s Note: Authors made conflict of interest disclosures. This work was supported in part by grants from the National Institute of Mental Health and the Commonwealth Research Center. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

 

# # #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email mediarelations@jamanetwork.org.